Were the CNO (CNO) insider share sales under a Rule 10b5-1 plan?

Yes. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on August 20, 2025. All three open-market sale transactions on February 17, 2026 are reported as occurring under this pre-adopted trading plan.

What indirect CNO (CNO) share holdings does Yvonne K. Franzese report?

In addition to directly held shares, Yvonne K. Franzese reports indirect ownership of 78,279 CNO common shares. These shares are held through the Yvonne K. Franzese Revocable Trust, which is specifically identified as the nature of indirect ownership in the filing.

What price ranges are disclosed for the CNO (CNO) insider share sales?

The filing notes that sales occurred within specified price ranges. Depending on the block, individual trades were executed between $42.94 and $43.79 per share, with each line reporting a single weighted average sale price within these disclosed ranges.

CNO Financial (NYSE: CNO) HR chief sells 9,000 shares

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

CNO Financial Group's Chief Human Resources Officer, Yvonne K. Franzese, sold 9,000 shares of common stock in three open-market transactions on February 17, 2026. The sales were made under a Rule 10b5-1 trading plan adopted on August 20, 2025.

The reported weighted average sale prices were $43.1807, $43.1744 and $43.1638 per share, with individual trades occurring within disclosed ranges between $42.94 and $43.79 per share. Franzese also reports indirect ownership of 78,279 common shares held through the Yvonne K. Franzese Revocable Trust.

Insider Trade Summary

Net Seller: 9,000 shares ($388,557)

Net Sell 4 txns

Insider Franzese Yvonne K.

Role Chief Human Resources Officer

Sold 9,000 shs ($389K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,000	$43.1638	$129K
Sale	Common Stock	3,000	$43.1807	$130K
Sale	Common Stock	3,000	$43.1744	$130K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 41,062 shares (Direct); Common Stock — 78,279 shares (Indirect, Yvonne K. Franzese Revocable Trust)

Footnotes (1)

Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 20, 2025. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $43.00 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.73 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Form 4 Insider Transactions: What Each Field Means →

02/18/2026 - 07:36 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Franzese Yvonne K.

(Last)

(First)

(Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL

46032

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/17/2026		S		3,000⁽¹⁾	D	$43.1638⁽²⁾	41,062	D
Common Stock	02/17/2026		S		3,000⁽¹⁾	D	$43.1807⁽³⁾	38,062	D
Common Stock	02/17/2026		S		3,000⁽¹⁾	D	$43.1744⁽⁴⁾	35,062	D
Common Stock								78,279	I	Yvonne K. Franzese Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 20, 2025.

2. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. Reflects the weighted average sale price. Shares were sold at prices ranging from $43.00 per share to $43.79 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

4. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.94 per share to $43.73 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CNO (CNO) report for Yvonne K. Franzese?

CNO reported that Chief Human Resources Officer Yvonne K. Franzese sold 9,000 shares of common stock on February 17, 2026. The transactions were open-market sales executed in three blocks under a Rule 10b5-1 trading plan adopted on August 20, 2025.

How many CNO (CNO) shares did the CHRO sell and at what prices?

Yvonne K. Franzese sold 9,000 CNO common shares in three transactions. The weighted average sale prices were $43.1807, $43.1744 and $43.1638 per share, with individual trade prices ranging from $42.94 to $43.79 per share across the reported blocks.

How many sale transactions did CNO’s CHRO execute in this Form 4?

The Form 4 reports three non-derivative open-market sale transactions in CNO common stock by Yvonne K. Franzese. Each transaction involves 3,000 shares sold on February 17, 2026, totaling 9,000 shares, all classified under transaction code “S” for sales.